Suspension of trading

Bellicum Pharmaceuticals, Inc. Stock

Stocks

BPXA

US0794814048

Biotechnology & Medical Research

OTC Markets Traded
Market Closed - Börse Stuttgart 5-day change 1st Jan Change
- EUR -.--% Intraday chart for Bellicum Pharmaceuticals, Inc. -2.31% -53.99%
Days
Hours
Minutes
Seconds
-40%
on all subscriptions*
Last hours
Enjoy this offer
* See conditions under "Our services"
3 years 0
Extreme 0
0.19
5 years 0
Extreme 0
0.19
10 years 0
Extreme 0
0.19
Manager TitleAgeSince
Chief Executive Officer 66 2024-02-22
Chief Executive Officer 58 2017-01-30
Director TitleAgeSince
Director/Board Member 58 -
Director/Board Member - -
Date Insider Type Main position Quantity % Market Cap.
23-11-21
Baker Bros. Advisors LP
OptionCompany 4,232,698 44.5721%
23-01-02Fiscal year

Director

74,739 0.8677%
23-01-02Fiscal year

Chairman

121,452 1.4100%
Change 5-day change 1-year change 3-year change Capi.($)
-.--%-2.31% - - 822K
+1.44%-1.25%+63.52%+114.88% 55.19B
+4.60%+3.02%+58.20%+47.16% 45.75B
-1.44%+0.39%-12.94%-19.24% 22.98B
-2.69%-2.10%-3.68%+379.00% 20.76B
+3.22%-0.84%+27.88%-34.00% 16.26B
+0.58%+1.08%+16.73%-38.06% 15.42B
-1.01%-2.30%+27.42%+171.92% 13.05B
+4.95%+11.70%+123.63%+252.19% 12.45B
+3.07%+0.14%+29.37% - 12.37B
Average +1.27%+1.78%+36.68%+109.23% 21.42B
Weighted average by Cap. +1.63%+1.48%+40.92%+99.91%

Financials

2021 2022
Net sales 6.2M 5.41M 5.01M 4.69M 8.79M 585M 8.84M 59.39M 23.02M 288M 23.27M 22.77M 1B 1.5M 1.31M 1.21M 1.13M 2.13M 142M 2.14M 14.37M 5.57M 69.67M 5.63M 5.51M 242M
Net income -9.7M -8.46M -7.84M -7.34M -13.76M -916M -13.84M -92.97M -36.03M -451M -36.43M -35.65M -1.57B -24.97M -21.77M -20.17M -18.88M -35.4M -2.36B -35.62M -239M -92.72M -1.16B -93.74M -91.73M -4.03B
Net Debt - -
Logo Bellicum Pharmaceuticals, Inc.
Bellicum Pharmaceuticals Inc is a United States-based company. The Company operates as a biopharmaceutical company focused on discovering and developing cellular immunotherapies for various forms of cancer.
Employees
13
  1. Stock Market
  2. Stocks
  3. BPXA Stock
LAST HOURS | 40% Discount: The Best Subscriber-Only Tools to Unlock Hidden Opportunities!
d
:
:
SEIZE THE OFFER!